U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H3FN2O
Molecular Weight 114.0778
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 5-FLUOROPYRIMIDIN-2-ONE

SMILES

FC1=CNC(=O)N=C1

InChI

InChIKey=HPABFFGQPLJKBP-UHFFFAOYSA-N
InChI=1S/C4H3FN2O/c5-3-1-6-4(8)7-2-3/h1-2H,(H,6,7,8)

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU).
2002 Feb
Guest-induced modification of a magnetically active ultramicroporous, gismondine-like, copper(II) coordination network.
2008 Mar 26
Capecitabine from X-ray powder synchrotron data.
2009 May 20
Patents
Name Type Language
5-FLUOROPYRIMIDIN-2-ONE
Systematic Name English
5-FLUORO-2(1H)-PYRIMIDINONE
Systematic Name English
2(1H)-PYRIMIDINONE, 5-FLUORO-
Systematic Name English
NSC-529069
Code English
2-HYDROXY-5-FLUOROPYRIMIDINE
Systematic Name English
4-DEOXY-5-FLUOROURACIL
Common Name English
Code System Code Type Description
EVMPD
SUB197488
Created by admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
PRIMARY
CAS
2022-78-8
Created by admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
PRIMARY
NSC
529069
Created by admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
PRIMARY
SMS_ID
100000183178
Created by admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
PRIMARY
PUBCHEM
101498
Created by admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
PRIMARY
FDA UNII
1VXI7T1BI5
Created by admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
PRIMARY
EPA CompTox
DTXSID90174067
Created by admin on Fri Dec 15 15:42:46 GMT 2023 , Edited by admin on Fri Dec 15 15:42:46 GMT 2023
PRIMARY